✦ LIBER ✦

Regulatory Cancer Risk Assessment Based on a Quick Estimate of a Benchmark Dose Derived from the Maximum Tolerated Dose

✍ Scribed by David W. Gaylor; Lois Swirsky Gold

Book ID: 115646844
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 47 KB
Volume: 28
Category: Article
ISSN: 0273-2300
DOI: 10.1006/rtph.1998.1258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quick Estimate of the Regulatory Virtual

Quick Estimate of the Regulatory Virtually Safe Dose Based on the Maximum Tolerated Dose for Rodent Bioassays

✍ D.W. Gaylor; L.S. Gold 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 653 KB

The Impact of Exercise and Intersubject

The Impact of Exercise and Intersubject Variability on Dose Estimates for Dichloromethane Derived from a Physiologically Based Pharmacokinetic Model

✍ David A. Dankovic; A.John Bailer 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 312 KB

Determination of the maximum tolerated d

Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: A report from the childrens cancer study group

✍ Feig, Stephen A. ;Krailo, Mark D. ;Harris, Richard E. ;Baum, Edward ;Holcenberg, 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 566 KB

## Abstract An escalating‐dose trial of idarubicin, used weekly for 3 doses in combination with vincristine, prednisone, and L‐asparaginase (VPLI), to reinduce remission of childhood ALL at first bone marrow relapse was conducted by the Childrens Cancer Study Group (CCSG). The maximum tolerated dos